TITAN BIO TECH
Q1 FY 21 RESULTS REVIEW
DT 18 08 2020
Management
Naresh Kumar Singla Managing Director
Suresh Chand Singla Managing Director
Titan Biotech Limited is a leading manufacturer & exporter of biological products used in the field of Pharmaceutical, Nutraceutical, Food & Beverages, Biotechnology & Fermentation, Cosmetic, Veterinary & Animal Feed, Agriculture Industries, Microbiology Culture Media & Plant Tissue Culture Media etc.
It supplies Biological Products like Ox Bile Extract, Peptones, Protein Hydrolysates, Amino Acid Mixtures, Liver Extracts, Culture Media & Plant Growth Promoters etc.
With the experience of more than 25 years and the remarkable market presence in 75+ countries, Titan Biotech is consistently pushing the boundaries of research and development to deliver the best quality of biological products.
It is committed to total customer satisfaction policy. This is achieved by providing its customers the highest quality products available along with the most responsive customer support services. Besides quality, it emphasises to supply the most competitive prices to the market in order to cater & create the success situation in marketplace.
Titan Biotech (in Rs. Cr.) |
Jun '20 |
Mar '20 |
Dec '19 |
Sep '19 |
Jun '19 |
YOY |
QOQ |
Net Sales |
39.42 |
20.08 |
18.76 |
18.51 |
22.09 |
78.45 |
96.31 |
Raw Materials |
14.81 |
9.54 |
9.66 |
9.35 |
11.7 |
26.58 |
55.24 |
Increase/Decrease in Stocks |
-0.67 |
-0.38 |
-0.68 |
0.06 |
0.11 |
-709.09 |
76.32 |
Employees Cost |
2.94 |
3.49 |
3.18 |
3.02 |
2.78 |
5.76 |
-15.76 |
Depreciation |
0.45 |
0.45 |
0.46 |
0.45 |
0.44 |
2.27 |
0 |
Other Expenses |
4.16 |
4.27 |
3.42 |
3.47 |
2.98 |
39.6 |
-2.58 |
P/L Before Other Inc., Int., Excpt. Items & Tax |
17.72 |
2.72 |
2.72 |
2.16 |
4.09 |
333.25 |
551.47 |
Other Income |
0.23 |
0.18 |
0.11 |
0.4 |
0.11 |
109.09 |
27.78 |
P/L Before Int., Excpt. Items & Tax |
17.96 |
2.9 |
2.82 |
2.56 |
4.2 |
327.62 |
519.31 |
Interest |
0.37 |
0.61 |
0.57 |
0.56 |
0.6 |
-38.33 |
-39.34 |
P/L Before Exceptional Items & Tax |
17.58 |
2.29 |
2.26 |
2 |
3.6 |
388.33 |
667.69 |
Exceptional Items |
0.09 |
-- |
0.26 |
-- |
-- |
#VALUE! |
|
P/L Before Tax |
17.67 |
2.29 |
2.52 |
2 |
3.6 |
390.83 |
671.62 |
Tax |
4.45 |
0.34 |
0.7 |
0.53 |
1 |
345 |
1208.82 |
Net Profit |
13.22 |
1.95 |
1.82 |
1.47 |
2.6 |
408.46 |
577.95 |
Minority Interest |
-0.48 |
-0.02 |
-0.06 |
-- |
-0.64 |
-25 |
2300 |
N P T |
12.74 |
1.92 |
1.76 |
1.47 |
1.96 |
550 |
563.54 |
Equity Share Capital |
8.26 |
8.26 |
8.26 |
8.26 |
8.26 |
0 |
0 |
Basic EPS FV 10 |
15.42 |
2.33 |
2.13 |
1.72 |
2.37 |
550.63 |
561.8 |
BSE Live 152.1 ON 17.08.20
52 Wk L/H 27.25 152.1
Historical Prices |
||||
1 YR |
Current Price |
%Gain / Loss |
||
Open Price |
34.5 |
103.5 |
200 |
|
2 YR |
||||
Open Price |
55.65 |
103.5 |
85.98 |
|
3 YR |
||||
Open Price |
68 |
103.5 |
52.21 |
|
3 MONTHS |
||||
Open Price |
49.25 |
103.5 |
110.15 |
|
Share Holding Pattern in (%) |
||||
Standalone |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Promoters |
54.35 |
54.35 |
53.98 |
49.73 |
Pledged |
0 |
0 |
0 |
0 |
FII/FPI |
0 |
0 |
0 |
0 |
Total DII |
19.59 |
19.72 |
19.82 |
28.94 |
Fin.Insts |
0 |
0 |
0 |
0 |
Insurance Co |
0 |
0 |
0 |
0 |
MF |
0 |
0 |
0 |
0 |
Others DIIs |
19.59 |
19.72 |
19.82 |
28.94 |
Others |
26.06 |
25.93 |
26.21 |
21.32 |
Total |
100 |
100 |
100.01 |
99.99 |
balance sheet |
|||||
Equities & Liabilities |
Mar-20 |
Mar-19 |
Mar-18 |
Mar-17 |
Mar-16 |
Share Capital |
8.26 |
8.26 |
7.74 |
7.74 |
7.74 |
Reserves & Surplus |
30.93 |
23.91 |
16.62 |
15.27 |
13.79 |
Current Liabilities |
20.43 |
15.78 |
11.01 |
12.25 |
12.66 |
Other Liabilities |
16.42 |
16.78 |
21.44 |
16.92 |
5.86 |
Total Liabilities |
76.04 |
64.73 |
56.81 |
52.18 |
40.05 |
Assets |
|||||
Fixed Assets |
31.23 |
29.02 |
26.99 |
22.17 |
15.81 |
Current Assets |
44.2 |
35.14 |
29.27 |
29.54 |
23.78 |
Other Assets |
0.61 |
0.57 |
0.55 |
0.47 |
0.46 |
Total Assets |
76.04 |
64.73 |
56.81 |
52.18 |
40.05 |
Other Info |
|||||
Contingent Liabilities |
0 |
0 |
0 |
0 |
0 |
STRENGTHS
Promoters increasing shareholding
Company with high TTM EPS Growth
Growth in Net Profit with increasing Profit Margin (QoQ) and YoY
Increasing Revenue every quarter for the past 3 quarters
Increasing profits every quarter for the past 3 quarters
Annual Net Profits improving for last 2 years
Company with Zero Promoter Pledge
Growth in Operating Profit with increase in operating margins (YoY)
Companies with rising net profit margins - quarterly as well as TTM basis
CHART
FROM APRIL 20, RISING UPWARD CURVE
FROM 33.90 TO OVER 100 NOW.
TECHNICAL RATING
Bullish
Valuation
Market Cap (Rs Cr.)
85.53
P/E
4.86
Book Value (Rs)
45.76
Dividend (%)
10
Industry P/E
65.8
EPS (TTM)
21.3
P/C
4.42
Price/Book
2.26
Dividend Yield.(%)
0.97
Face Value (RS)
10
Deliverables (%)
99.96
Note : Presently, BUYERS ONLY stock for last several days
No comments:
Post a Comment